Dopamine D2 receptors mapped in rat brain with [3H](+)PHNO

Synapse. 1994 Jul;17(3):167-72. doi: 10.1002/syn.890170305.

Abstract

Previous work with membrane preparations had demonstrated that the agonist (+)-4-propyl-9-hydroxynaphthoxazine (PHNO) labels the high-affinity state of dopamine D2 receptors with 67-fold selectivity over D1 sites. In this study, quantitative autoradiography was used to examine the binding of [3H](+)PHNO to rat brain sections. Highest binding densities were found in caudate-putamen, accumbens, and olfactory tubercles, as expected, and also in specific layers of the olfactory bulb. In addition, a second group of brain regions, including lateral septum, entorhinal cortex, molecular layer of hippocampus, and several brainstem structures showed low but consistent levels of binding. In all brain regions [3H](+)PHNO binding (2 nM) was completely displaced by 10 microM sulpiride (> 99%). Addition of 150 microM guanilylimidodiphosphate, which normally converts D2 receptors from high to low affinity states, abolished [3H](+)PHNO binding in all brain regions (> 99%), except for the islands of Callejas. This is likely to reflect binding to D3 sites in this area. Omission of preincubation in binding assays decreased [3H](+)PHNO binding in a regionally dependent manner, with strongest effects (22%) seen in high-density areas. These preincubation results confirm that (+)PHNO may have limitations for in vivo imaging studies. On the other hand, [3H](+)PHNO's negligible levels of non-specific binding compared to other agonists and overall selectivity would make it an excellent tool for in vitro autoradiographic monitoring of the high affinity state of D2 receptors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Autoradiography
  • Brain / anatomy & histology*
  • Brain / drug effects
  • Brain Chemistry / drug effects*
  • Brain Mapping*
  • Densitometry
  • Dopamine Agonists*
  • Dopamine Antagonists / pharmacology
  • Dopamine D2 Receptor Antagonists*
  • Guanine Nucleotides / pharmacology
  • Guanylyl Imidodiphosphate / pharmacology
  • In Vitro Techniques
  • Ligands
  • Male
  • Oxazines*
  • Raclopride
  • Rats
  • Rats, Wistar
  • Salicylamides / pharmacology
  • Spiperone / pharmacology

Substances

  • Dopamine Agonists
  • Dopamine Antagonists
  • Dopamine D2 Receptor Antagonists
  • Guanine Nucleotides
  • Ligands
  • Oxazines
  • Salicylamides
  • naxagolide
  • Guanylyl Imidodiphosphate
  • Raclopride
  • Spiperone